GeneDx Holdings Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, GeneDx Holdings stock has a consensus rating of "Strong Buy" and an average price target of $90.44. The average 1-year stock price forecast is 0.90% lower than the current stock price, while the lowest is $74 (-18.91%) and the highest is $103 (+12.86%).

Price Target: $90.44 (-0.90%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$74	$90.44	$90	$103
Change	-18.91%	-0.90%	-1.38%	+12.86%

Analyst Ratings

The average analyst rating for GeneDx Holdings stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	8	8	8	8	8	8
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	9	9	9	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
William Bonello Craig-Hallum	Craig-Hallum	Buy Maintains $85 → $103	Buy	Maintains	$85 → $103	+12.86%	Aug 4, 2026
Brandon Couillard Wells Fargo	Wells Fargo	Buy Maintains $75	Buy	Maintains	$75	-17.82%	Aug 4, 2026
Mark Massaro BTIG	BTIG	Buy Reiterates $90	Buy	Reiterates	$90	-1.38%	Aug 4, 2026
Kyle Mikson CFA Canaccord Genuity	Canaccord Genuity	Buy Reiterates $75 → $90	Buy	Reiterates	$75 → $90	-1.38%	Aug 4, 2026
David Westenberg Piper Sandler	Piper Sandler	Buy Maintains $63	Buy	Maintains	$63	-30.97%	Aug 4, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

481.59M

from 427.54M

12.64%

from 427.54M

Revenue Next Year

598.54M

from 481.59M

24.29%

from 481.59M

EPS This Year

0.12

from 1.40

-91.57%

from 1.40

EPS Next Year

1.17

from 0.12

890.47%

from 0.12

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	212.20M	234.69M	202.57M	305.45M	427.54M	481.59M
Revenue Growth	18.33%	10.60%	-13.69%	50.79%	39.97%	12.64%
Gross Profit	-16.60M	-26.75M	90.15M	194.45M	298.18M	336.79M
Gross Margin	-7.82%	-11.40%	44.50%	63.66%	69.74%	69.93%
Operating Income	-446.15M	-457.51M	-170.06M	-23.16M	-11.67M	5.48M
Net Income	-245.39M	-548.98M	-175.77M	-52.29M	-21.02M	-94.48M
EPS	-	-	-	-	1.40	0.12
EPS Growth	-	-	-	-	460.67%	-91.57%
Forward PE	-	-	-	190.96	250.14	773.39
Free Cash Flow	-43.99M	-172.97M	-124.34M	-1.16M	38.06M	-69.90M
No. Analysts	-	-	-	-	-	10

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	484.3M
Avg	481.6M
Low	478.0M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	13.3%
Avg	12.6%
Low	11.8%

EPS Forecast

Chart

EPS	2026	2027	2028
High	0.32
Avg	0.12
Low	0.02

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-77.1%
Avg	-91.6%
Low	-98.6%